Ovarian Tissue Freezing for Infertility
Trial Summary
What is the purpose of this trial?
The purpose of this study is to offer an alternative method to women who wish to preserve the possibility of fertility, as well as to learn more about the ability of human eggs to survive and function after long term storage in frozen ovaries (ovarian tissue cryopreservation). The study will seek to preserve ovarian tissue and reproductive potential for patients whose medical or surgical treatment may harm ovaries or remove ovarian tissue.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify if you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the idea that Ovarian Tissue Freezing for Infertility is an effective treatment?
The available research shows that Ovarian Tissue Freezing is effective for preserving fertility, especially for women undergoing treatments like chemotherapy that can harm fertility. One study reviewed 545 cases and found that the treatment is promising for fertility preservation. Another study highlighted successful pregnancy rates in patients who used this method for non-cancer reasons. Additionally, there are reports of live births following the procedure, indicating its potential effectiveness in helping women have children after undergoing the treatment.12345
What safety data exists for ovarian tissue freezing for infertility?
The provided research does not contain relevant safety data for ovarian tissue freezing, ovarian tissue cryopreservation, or OTC in the context of infertility treatment. The studies focus on unrelated topics such as over-the-counter cold remedies, drug regulations, minoxidil side effects, homeopathy, and dietary supplements. Therefore, no specific safety data for ovarian tissue freezing is available in the given research.678910
Is Ovarian Tissue Freezing a promising treatment for infertility?
Research Team
David M Lee, MD
Principal Investigator
Oregon Health and Sciences University
Eligibility Criteria
This trial is for women aged 18-41 who may lose ovarian function due to medical treatments like surgery, chemotherapy, or radiation for conditions such as cancer. It's also open to those needing ovary removal and have not had previous therapy likely to cause permanent ovarian damage. Participants must be able to give informed consent.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Ovarian Tissue Freezing
Ovarian Tissue Freezing is already approved in European Union, United States for the following indications:
- Fertility preservation for cancer patients
- Fertility preservation for pre-pubertal girls
- Fertility preservation for individuals undergoing gender affirmation surgery
- Fertility preservation for cancer patients
- Fertility preservation for pre-pubertal girls
- Fertility preservation for individuals undergoing gender affirmation surgery
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oregon Health and Science University
Lead Sponsor